Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece.
Gatopoulou A, Christodoulou DK, Katsanos KH, Bakos D, Mouzas I, Tzouvala M, Theodoropoulou A, Paspatis G, Theocharis G, Thomopoulos K, Giouleme O, Kourikou A, Manolakopoulos S, Zampeli E, Michopoulos S, Karatzas P, Katsaros M, Moschovis D, Orfanoudaki E, Livieratos A, Petrikkou E, Mantzaris GJ.
Gatopoulou A, et al. Among authors: petrikkou e.
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e615-e624. doi: 10.1097/MEG.0000000000002182.
Eur J Gastroenterol Hepatol. 2021.
PMID: 34034278